TY - JOUR
KW - Analgesics, Opioid/therapeutic use
KW - Buprenorphine/therapeutic use
KW - Humans
KW - Methadone/therapeutic use
KW - Naltrexone/therapeutic use
KW - Opioid-Related Disorders/drug therapy
KW - United States
AU - T. Nalven
AU - N. S. Spillane
AU - M. R. Schick
AU - L. L. Weyandt
A1 - 
AD - Department of Psychology, University of Rhode Island.; Department of Psychology, University of Rhode Island.; Department of Psychology, University of Rhode Island.; Department of Psychology, University of Rhode Island.
BT - Experimental and clinical psychopharmacology
C5 - Healthcare Disparities; Opioids & Substance Use
CP - 5
DO - 10.1037/pha0000510
IS - 5
JF - Experimental and clinical psychopharmacology
LA - eng
M1 - Journal Article
PY - 2021
SN - 1936-2293; 1064-1297; 1064-1297
SP - 524
EP - 538
EP - 
T1 - Diversity inclusion in United States opioid pharmacological treatment trials: A systematic review
T2 - Experimental and clinical psychopharmacology
TI - Diversity inclusion in United States opioid pharmacological treatment trials: A systematic review
U1 - Healthcare Disparities; Opioids & Substance Use
U2 - 34242040
U3 - 10.1037/pha0000510
VL - 29
VO - 1936-2293; 1064-1297; 1064-1297
Y1 - 2021
Y2 - Oct
ER -